8 Recruiting Crohn's Disease Clinical Trials in Arizona
Explore active crohn's disease research studies enrolling across Arizona. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Crohn's Disease Studies in Arizona
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
📍 Gi Alliance - Arizona Digestive Health - Sun City /ID# 268178 — Sun City, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
📍 Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211884 — Mesa, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
📍 GI Alliance - Sun City — Sun City, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase4 📋 Clinical Research Protocol
A Study of CDPATH™ to Help Manage and Treat Crohn's Disease
📍 Arizona Arthritis & Rheumatology Research, PLLC — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
📍 Investigational Site Number: 8400024 — Tucson, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
📍 GI Alliance - Arizona Digestive Health - Sun City- Site Number : 8400020 — Sun City, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
📍 Phoenix Children's Hospital /ID# 255766 — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
📍 Onyx Clinical Research - Site Number: 8400021 — Peoria, Arizona
View Study & Checklist ➔